Primary FDA-Approved Indications
Reserve cefadroxil for streptococcal pharyngitis in penicillin-allergic patients without immediate reactions, uncomplicated skin/soft-tissue infections, and selected urinary tract infections based on susceptibility.
Group A streptococcal pharyngitis/tonsillitis
FDA ApprovedSuitable for children with mild non-IgE penicillin reactions when once- or twice-daily dosing aids adherence.
Evidence Sources
Uncomplicated skin and soft-tissue infections (MSSA, streptococcal impetigo/cellulitis)
FDA ApprovedProvides broader staphylococcal coverage than penicillin VK; combine with incision and drainage when indicated.